Polymerase chain reaction (PCR) test detects more oesophageal cancers:
This article was originally published in Clinica
Testing for the biochemical marker carcinoembryonic antigen (CEA) could increase the detection of cancer spread from the oesophagus, US researchers have said. Using reverse transcriptase PCR, researchers at the University of Pittsburgh analysed 123 lymph nodes from 30 patients with oesophageal cancer. Of the 73 nodes that were negative on histology, 33 were found to have CEA mRNA and would therefore be classed as node-positive tumours. Use of the test increased the number of node-positive tumours from 41% to 70%.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.